Literature DB >> 29769895

Documenting the elimination of measles, rubella and congenital rubella syndrome in Ontario: 2009-12.

G H Lim1, S L Deeks1,2, J Fediurek1, J Gubbay1,3,4, N S Crowcroft1,2,4.   

Abstract

BACKGROUND: Under the guidance of the Pan American Health Organization (PAHO), countries of the Americas are currently documenting the elimination of measles, rubella, and congenital rubella syndrome.
OBJECTIVE: This paper describes Ontario's progress in documenting the elimination of these conditions between 2009 and 2012.
METHODS: All possible case classifications, including those that did not meet surveillance case definitions, were extracted from the provincial reportable disease database, the integrated Public Health Information System (iPHIS). Data were analyzed against select criteria specified by the PAHO, specifically with respect to epidemiology, vaccination coverage, and the quality of the surveillance system.
RESULTS: There were no known endemic cases of measles, rubella or congenital rubella syndrome reported in Ontario during the study period. Cases were predominantly the result of importation, as these diseases remain endemic in many countries. A total of 27 confirmed cases of measles were reported over the four-year period, most of which could be verified as being directly or indirectly linked with travel outside Canada. In addition, five confirmed cases of rubella and one case of imported congenital rubella syndrome were identified. A review of immunization coverage and surveillance data quality identified gaps. The combined annual rates of suspected measles and rubella cases (between 0.7 and 1.1 cases per 100,000 population) and suspected congenital rubella syndrome cases (0.21 to 0.49 cases per 10,000 live births) were below PAHO's thresholds. Also, the frequent absence of immunization and travel histories within iPHIS was of concern (77.3% and 44.6% respectively).
CONCLUSION: These results support Ontario's sustained elimination status. However, in order to satisfactorily meet PAHO's requirements for documenting the elimination of these diseases, continued vigilance is required. Efforts are currently under way within Ontario to improve reporting.

Entities:  

Year:  2014        PMID: 29769895      PMCID: PMC5864482          DOI: 10.14745/ccdr.v40i08a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  3 in total

Review 1.  Epidemiology of transmissible diseases after elimination.

Authors:  G De Serres; N J Gay; C P Farrington
Journal:  Am J Epidemiol       Date:  2000-06-01       Impact factor: 4.897

2.  Enhanced surveillance for measles in low-incidence territories of the Russian Federation: defining a rate for suspected case investigation.

Authors:  N T Tikhonova; M A Bichurina; A G Gerasimova; O V Zvirkun; N P Vladimerova; T Mamaeva; G Lipskaya; S Elsaadany; J S Spika
Journal:  Epidemiol Infect       Date:  2010-04-06       Impact factor: 2.451

3.  Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas.

Authors:  Carlos Castillo-Solórzano; Susan E Reef; Ana Morice; Jon Kim Andrus; Cuauthémoc Ruiz Matus; Gina Tambini; Socorro Gross-Galiano
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

  3 in total
  2 in total

1.  The challenges of sustaining measles elimination in Canada.

Authors:  N S Crowcroft
Journal:  Can Commun Dis Rep       Date:  2014-06-12

2.  The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014.

Authors:  Shelly Bolotin; Gillian Lim; Vica Dang; Natasha Crowcroft; Jonathan Gubbay; Tony Mazzulli; Richard Schabas
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.